Literature DB >> 21993190

Diabetes in Cushing syndrome: basic and clinical aspects.

Gherardo Mazziotti1, Carmine Gazzaruso, Andrea Giustina.   

Abstract

Diabetes mellitus is a frequent complication of Cushing syndrome (CS) which is caused by chronic exposure to glucocorticoid excess, either endogenous or exogenous, and that is characterized by several clinical symptoms such as central obesity, purple striae, proximal muscle weakness, acne, hirsutism and neuropsychological disturbances. Diabetes occurs as a consequence of an insulin-resistant state together with impaired insulin secretion which are induced by glucocorticoid excess. The management of patients with CS and diabetes mellitus includes the treatment of hyperglycemia and, when possible, the correction of glucocorticoid excess. This review focuses on the disorders of glucose metabolism in patients exposed to glucocorticoid excess, addressing both the pathophysiological aspects and the clinical and therapeutic implications.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21993190     DOI: 10.1016/j.tem.2011.09.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  61 in total

Review 1.  The Interplay Between Pituitary Health and Diabetes Mellitus - The Need for 'Hypophyseo-Vigilance'.

Authors:  Saptarshi Bhattacharya; Sanjay Kalra; Deep Dutta; Deepak Khandelwal; Rajiv Singla
Journal:  Eur Endocrinol       Date:  2019-10-18

2.  Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study.

Authors:  Christoph Beglinger; Ke Hu; Ying Wang; Emmanuel Bouillaud; Christelle Darstein; Yanfeng Wang; Pharis Mohideen
Journal:  Endocrine       Date:  2012-04-21       Impact factor: 3.633

Review 3.  Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

Authors:  M G Baroni; F Giorgino; V Pezzino; C Scaroni; A Avogaro
Journal:  J Endocrinol Invest       Date:  2015-12-30       Impact factor: 4.256

4.  The effect of steroid pulse therapy on carbohydrate metabolism in multiple myeloma patients: a randomized crossover observational clinical study.

Authors:  O Véber; A Wilde; J Demeter; G Tamás; I Mucsi; A G Tabák
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

5.  Comparison of the efficacy of liraglutide with pioglitazone on dexamethasone induced hepatic steatosis, dyslipidemia and hyperglycaemia in albino rats.

Authors:  K Vinodraj; I M Nagendra Nayak; J Vikram Rao; Paul Mathai; N Chandralekha; B Nitasha; D Rajesh; T K Chethan
Journal:  Indian J Pharmacol       Date:  2015 Mar-Apr       Impact factor: 1.200

Review 6.  Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment.

Authors:  Jessica L Hwang; Roy E Weiss
Journal:  Diabetes Metab Res Rev       Date:  2014-02       Impact factor: 4.876

7.  Biopsychosocial pathways linking subjective socioeconomic disadvantage to glycemic control in youths with type I diabetes.

Authors:  Samuele Zilioli; Deborah A Ellis; Justin M Carré; Richard B Slatcher
Journal:  Psychoneuroendocrinology       Date:  2017-02-03       Impact factor: 4.905

8.  New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.

Authors:  Heather A Ferris; C Ronald Kahn
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 9.  Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?

Authors:  Sachin K Majumdar; Silvio E Inzucchi
Journal:  Endocrine       Date:  2013-01-25       Impact factor: 3.633

Review 10.  Glucocorticoids and the regulation of growth hormone secretion.

Authors:  Gherardo Mazziotti; Andrea Giustina
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.